Systemic treatments in recurrent or metastatic salivary gland cancer: a systematic review.

ABSTRACT:

Background

Salivary gland cancers are infrequent and pose a challenge owing to their histological diversity and varied clinical behavior, making the selection of optimal systemic treatments for advanced or recurrent stages difficult. This systematic review aims to assess overall survival outcomes and systemic treatment responses across four types of salivary cancers.

Methods

A PubMed and Google Scholar search identified studies involving initially advanced or relapsed cases undergoing systemic treatment. Studies with clear, individualized data on treatment responses and outcomes were selected based on the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) checklist. Of the 723 studies screened, 44 met our inclusion criteria.

Results

A total of

SUBMITTER: Prost D 

PROVIDER: S-EPMC11490782 | biostudies-literature | 2024 Oct

REPOSITORIES: biostudies-literature